NEW YORK. NY / ACCESS Newswire / August 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AVITA Medical, Inc. ("AVITA" or "the Company") (NASDAQ:RCEL). Investors who purchased AVITA securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RCEL.
Investigation Details
On August 7, 2025, AVITA released its second quarter 2025 financial results, revealing "a six-month backlog in unpaid provider claims for Recell procedures impacted first-half demand." The Company explained that contractors assigned by the Centers for Medicare & Medicaid Services to determine pricing of the Company’s wound care product, Recell, "neither assigned a price or assigned an inadequate price and failed to adjudicate claims in a timely manner." As a result, "claims accumulated from January through June, creating a significant backlog of unpaid claims and inadequately paid claims to providers for RECELL procedures. This lack of resolution created uncertainty among providers regarding payment expectations and timelines, which led to a reduction in RECELL utilization during the first half of the year." Following this news, AVITA’s stock price dropped.
What’s Next?
If you are aware of any facts relating to this investigation or purchased AVITA securities, you can assist this investigation by visiting the firm’s site: bgandg.com/RCEL. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
COMTEX_468321181/2457/2025-08-26T11:02:23